Navigation Links
Blake M. Paterson MD, CEO and Co-founder of Alba Therapeutics, Wins Greater Baltimore Committee 2008 Leadership in Bioscience Award
Date:3/18/2008

ed the growth of Alba Therapeutics since its inception in 2004, and his leadership has been characterized by methodical and rapid growth. Alba has grown into a thriving Baltimore biotechnology company with 45 employees in its headquarters at the University of Maryland BioPark, and this growth has been punctuated by a series of significant milestones including securing significant venture financing, rapid progress of Alba's clinical candidate (larazotide acetate) into Phase 2b clinical trials, and closure of a licensing and collaboration agreement worth up to $325 million with Shire Pharmaceuticals.

About Alba

Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Alba's technology platform is based upon a key pathway that regulates the assembly and disassembly of tight junctions in cell barriers throughout the body. As a result of its unique technology platform, Alba is a leader in mucosal biology and has developed a pipeline of innovative therapeutic candidates that has the potential to modify the course of disease and significantly improve upon existing treatments for a wide range of diseases such as celiac disease, Crohn's disease, and Asthma/COPD or acute lung injury.

Contact: Bernard McDonald, PhD

Phone: 410-319-0780

E-mail: info@albatherapeutics.com

Web site: http://www.albatherapeutics.com


'/>"/>
SOURCE Alba Therapeutics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
2. Logical Therapeutics Co-Founder and CEO Honored with a Distinguished Investigator Award from the American College of Critical Care Medicine
3. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
4. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
5. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
6. Nile Therapeutics, Inc. Adds to Executive Management Team
7. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
8. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
9. Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results
10. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
11. Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... May 26, 2015 Global Stem ... announced plans for the company’s first cellular and regenerative ... by a full day, hands-on stem cell training class ... Victor Garcia Gimenez, M.D., President of Therapeutic Confrontations (CONFTERA) ... community’s increasing interest in regenerative medicine and recent advances ...
(Date:5/26/2015)... FORT WORTH, Texas , May 26, 2015 /PRNewswire-USNewswire/ ... North Texas Health Science Center to detect early Alzheimer,s ... screen older adults. Detailed standardized guidelines that ... in practice have been published in Alzheimer,s & ... continued efforts of an international working group that includes ...
(Date:5/26/2015)... , 26. mája 2015 ... mene svojej rodiny prezidentom Barackovi Obamovi a Billovi ... súvislosti so stratou Dr. Rongxiang Xu , ... http://photos.prnewswire.com/prnh/20150522/218111 Dr. Xu bol pionier, ... a jeho odhodlanie v oblasti vedy a príkladné ...
(Date:5/26/2015)... JERUSALEM , May 26, 2015 ... http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has submitted the study protocol for the company,s ... to the U.S. Food and Drug Administration (FDA). The ... Drug (IND) application. The Phase IIb study ...
Breaking Biology Technology:Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 2Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 3Guidelines bring UNT Health Science Center's blood test for Alzheimer's one step closer 2Dr. Rongxiang Xu, O legende 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 3
... Dec. 21, 2010 Exagen Diagnostics, Inc., a specialty ... today announced that it has been awarded $400,000 in ... program, which was created by Congress as part of ...  Proceeds from the grants will be used to advance ...
... M. Golubieski, president of Foundation Venture Capital Group, LLC, ... Snowdon Inc., a company in which FVCG has invested, ... of Defense (DoD) Program, Transformational Medical Technologies (TMT). ... (DTRA) contract, Snowdon may receive up to $8.2 million ...
... knows how to make an exact cut on a metal rod. ... a carbon nanotube, with a diameter 1/50,000th the thickness of a ... British journal Proceedings of the Royal Society A , researchers ... how single-walled carbon nanotubes are cut, a finding that could lead ...
Cached Biology Technology:Exagen Diagnostics Awarded $400,000 in Grants Under the QTDP Program 2Foundation Venture Capital Group Company Receives $8.2 Million DoD Contract 2Foundation Venture Capital Group Company Receives $8.2 Million DoD Contract 3How do you cut a nanotube? Lots of compression 2
(Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
(Date:4/21/2015)... April 21, 2015 High ... policies are boosting access control systems market in ... to a recently published report by TechSci Research " ... the access control systems market in Saudi ... by 2020.The access control systems market in the Kingdom ...
(Date:4/14/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... New York Design Awards under the category  ,Product Design ... Design Awards are part of a global multi-disciplinary awards ... from the marketplace, industry and judging panel. Winners will ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... to remove contaminants from soil, scientists at the ... and their Belgium colleagues at Hasselt University have ... on marginal land. The findings, published in the ... Environmental Microbiology , may help scientists design strategies ...
... the FDA has approved the first human clinical trial ... considerations, but not only, or even primarily, because what ... Although deep-seated disagreements about the ethics of embryo ... to focus as well on this being the first ...
... (ACMG) will hold its 16th Annual Clinical Genetics Meeting ... at the Tampa Convention Center. Clinical and medical ... a dizzying pace and the 2009 ACMG Annual Clinical ... and scientific media to learn firsthand about the latest ...
Cached Biology News:Scientists identify bacteria that increase plant growth 2Scientists identify bacteria that increase plant growth 3Far-reaching genetics topics to be addressed: 2009 Annual Clinical Genetics Meeting, March 25-29 2
...
... This monoclonal antibody recognizes 30% of ... individuals. It does not cross-react ... lacking rheumatoid factor nor with pooled ... used in ELISA to detect rheumatoid ...
...
Human VEGF R2 (KDR) MAb (Clone 89106)...
Biology Products: